Literature DB >> 25029106

In vitro and in vivo studies on adlay-derived seed extracts: phenolic profiles, antioxidant activities, serum uric acid suppression, and xanthine oxidase inhibitory effects.

Mouming Zhao1, Dashuai Zhu, Dongxiao Sun-Waterhouse, Guowan Su, Lianzhu Lin, Xiao Wang, Yi Dong.   

Abstract

This study aimed to explore the potential of polished adlay, brown adlay, adlay bran, and adlay hull to prevent and treat hyperuricemia. Brown adlay extract effectively decreased the serum uric acid levels of oxonate-induced hyperuricemic rats. Free and bound phenolic extracts from these materials contained significant amounts of phenolics, with free phenolics dominated by chlorogenic acid and p-coumaric acid while bound phenolics dominated by p-coumaric acid and ferulic acid. Free and bound phenolics of adlay bran exhibited significant xanthine oxidase inhibition activities, 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activities, oxygen radical absorbance capacities, and superoxide radical scavenging activities. Adlay bran phenolics could be effective xanthine oxidase inhibitors and radical scavengers. p-Coumaric acid is a xanthine oxidase inhibitor with strong superoxide radical scavenging activity. However, ferulic acid is a xanthine oxidase inhibitor with weak superoxide radical scavenging activity. Chlorogenic acid is a superoxide radical scavenger with weak xanthine oxidase inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25029106     DOI: 10.1021/jf501952e

Source DB:  PubMed          Journal:  J Agric Food Chem        ISSN: 0021-8561            Impact factor:   5.279


  9 in total

1.  MECHANISMS OF COIX SEED COMPOSITIONS IN THE TREATMENT OF SPLEEN DEFICIENCY AND WET DAMPNESS ZHENG.

Authors:  Xiaochun Han; Xuming Ji; Haijun Zhao; Yanan Zhang; Guowei Liu; Yanfang Wang; Wenxiao Zhao; Shijun Wang
Journal:  Afr J Tradit Complement Altern Med       Date:  2017-06-05

2.  In Vitro and In Vivo Studies on Quercus acuta Thunb. (Fagaceae) Extract: Active Constituents, Serum Uric Acid Suppression, and Xanthine Oxidase Inhibitory Activity.

Authors:  In-Soo Yoon; Dae-Hun Park; Min-Suk Bae; Deuk-Sil Oh; Nan-Hui Kwon; Jung-Eun Kim; Chul-Yung Choi; Seung-Sik Cho
Journal:  Evid Based Complement Alternat Med       Date:  2017-03-22       Impact factor: 2.629

3.  Food-Drug Interaction between the Adlay Bran Oil and Drugs in Rats.

Authors:  Hsien-Tsung Yao; Jia-Hsuan Lin; Yun-Ta Liu; Mei-Ling Li; Wenchang Chiang
Journal:  Nutrients       Date:  2019-10-15       Impact factor: 5.717

Review 4.  Bioactive Compounds from Plant-Based Functional Foods: A Promising Choice for the Prevention and Management of Hyperuricemia.

Authors:  Lin-Lin Jiang; Xue Gong; Ming-Yue Ji; Cong-Cong Wang; Jian-Hua Wang; Min-Hui Li
Journal:  Foods       Date:  2020-07-23

5.  Urinary Metabolomic Profiling after Administration of Corydalis Tuber and Pharbitis Seed Extract in Healthy Korean Volunteers.

Authors:  Hyeon-Cheol Jeong; Jung Eun Park; Yohan Seo; Min-Gul Kim; Kwang-Hee Shin
Journal:  Pharmaceutics       Date:  2021-04-09       Impact factor: 6.321

6.  Quantification and cytoprotection by vanillin, 4-methylguaiacol and 4-ethylguaiacol against AAPH-induced abnormal oxidative stress in HepG2 cells.

Authors:  Dongrui Zhao; Dongmei Shi; Jinyuan Sun; Hehe Li; Mouming Zhao; Baoguo Sun
Journal:  RSC Adv       Date:  2018-10-16       Impact factor: 4.036

7.  Regular exercise combined with ferulic acid exhibits antiobesity effect and regulates metabolic profiles in high-fat diet-induced mice.

Authors:  Ou Wang; Nanhai Zhang; Chao Han; Jian Huang
Journal:  Front Nutr       Date:  2022-07-27

8.  Changes in Triacylglycerols Content and Quality Control Implications of Coix Seeds during Processing and Storage.

Authors:  Weiwei Tang; Jiancheng Wang; Wei Li; Chaojun Zhang; Ping Li; Jun Chen
Journal:  Foods       Date:  2022-08-16

9.  Prophylactic Treatment with Adlay Bran Extract Reduces the Risk of Severe Acute Radiation Dermatitis: A Prospective, Randomized, Double-Blind Study.

Authors:  Chih-Jen Huang; Ming-Feng Hou; Jung-Yu Kan; Chiung-Hui Juan; Shyng-Shiou F Yuan; Kuei-Hau Luo; Hung-Yi Chuang; Stephen Chu-Sung Hu
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-01       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.